AU1618901A - Treatment of rosacea - Google Patents
Treatment of rosaceaInfo
- Publication number
- AU1618901A AU1618901A AU16189/01A AU1618901A AU1618901A AU 1618901 A AU1618901 A AU 1618901A AU 16189/01 A AU16189/01 A AU 16189/01A AU 1618901 A AU1618901 A AU 1618901A AU 1618901 A AU1618901 A AU 1618901A
- Authority
- AU
- Australia
- Prior art keywords
- rosacea
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16623599P | 1999-11-18 | 1999-11-18 | |
US60166235 | 1999-11-18 | ||
PCT/US2000/031623 WO2001035965A1 (fr) | 1999-11-18 | 2000-11-17 | Traitement de l'acne rosacee |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1618901A true AU1618901A (en) | 2001-05-30 |
Family
ID=22602396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU16189/01A Abandoned AU1618901A (en) | 1999-11-18 | 2000-11-17 | Treatment of rosacea |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1618901A (fr) |
WO (1) | WO2001035965A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1318588B1 (it) * | 2000-06-20 | 2003-08-27 | Helsinn Healthcare Sa | Uso della nimesulide nel trattamento di patologie dermatologiche. |
IL142037A0 (en) * | 2001-03-15 | 2002-03-10 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug |
FR2866566A1 (fr) * | 2004-02-20 | 2005-08-26 | Galderma Res & Dev | Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee |
FR2866567A1 (fr) * | 2004-02-20 | 2005-08-26 | Galderma Res & Dev | Utilisation d'un antagoniste du recepteur beta-adrenergique, at1, 5-ht2, 5-ht5 et/ou de la galanine, pour le traitement de la rosacee |
US11851474B2 (en) | 2017-02-23 | 2023-12-26 | Preclinics Gesellschaft Für Präklinische Forschung Mbh | Modified serpins for the treatment of bradykinin-mediated disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2737408B1 (fr) * | 1995-07-31 | 1997-09-05 | Oreal | Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
-
2000
- 2000-11-17 AU AU16189/01A patent/AU1618901A/en not_active Abandoned
- 2000-11-17 WO PCT/US2000/031623 patent/WO2001035965A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001035965A1 (fr) | 2001-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020501A (en) | Chemotherapy treatment | |
AU2002223827A1 (en) | Well treatment | |
AU5215300A (en) | Dental treatment area | |
AU3896900A (en) | Treatment of pain | |
AU5547000A (en) | Novel treatment | |
AU1916601A (en) | Oncolytic combinations for the treatment of cancer | |
AUPQ232599A0 (en) | Drug for treating fractures | |
AU1916501A (en) | Oncolytic combinations for the treatment of cancer | |
AU4556800A (en) | Novel treatment | |
AU1618901A (en) | Treatment of rosacea | |
AU3760900A (en) | Treatment of menstrual function | |
AUPQ367699A0 (en) | Treatment of cancer | |
AU5552400A (en) | Treatment of cancer | |
AU1917101A (en) | Oncolytic combinations for the treatment of cancer | |
AU1595001A (en) | Oncolytic combinations for the treatment of cancer | |
AU1595101A (en) | Oncolytic combinations for the treatment of cancer | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
AU1405001A (en) | Treatment of diseases | |
AU2001281465A1 (en) | Treatment of rosacea | |
AU4598400A (en) | Method of treatment | |
AU2001253560A1 (en) | Methods of treatment | |
AU2382601A (en) | Novel method of treatment | |
AU3798500A (en) | Verotoxin treatment of lymphomas | |
AU2616201A (en) | Cancer treatment method | |
AU1592901A (en) | Oncolytic combinations for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |